Loading people...
Yury Kukushkin is currently an Investment Partner at the Hevolution Foundation, where he focuses on private capital investments within the global biotechnology and life sciences sectors. Before joining his current organization, he served as a Managing Director and Investment Director at the JDRF T1D Fund, directing venture capital toward diabetes-focused therapeutics and related medical technologies. His institutional investment career also includes significant experience working with the investment firm 4BIO Capital, where he evaluated and executed various early-stage financial deals specifically targeting the rapidly growing advanced therapies space. Kukushkin holds a PhD, allowing him to leverage his extensive scientific training to assess complex biological technologies and guide portfolio companies through rigorous clinical development phases. Ultimately, his professional background centers on deploying specialized venture capital to accelerate the commercialization of advanced medical therapies and innovative biotech platforms.
Yury Kukushkin is Investor at T1D Fund, based in Boston, MA, USA.